Analyst Ratings for Affimed Therapeutics (AFMD)
AFMD Rating Summary
AFMD Price Target Summary
- Highest: $25.00 (Wells Fargo)
- Lowest: $5.00 (Stifel)
- Average: $12.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$12.00 (+155.9%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
Avg. $ Target:
$12.00 (+155.9%)
* Over Last 12-Mos
Rating Score: 9.2 / 10
Percentile Rank: 90%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2023 | Berenberg | Andy Chen | New Coverage | Buy (N/A) |
6.00 (N/A) |
0.60 (4.69) |
681.67% | Details |
| 3/27/2023 | Wells Fargo » Updated 4/1/2024 |
Yanan Zhu | New Coverage | Overweight (N/A) |
25.00 (30.00) |
0.66 (4.69) |
610.61% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
